These final results, along with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,two guidance the principle of targeting ACKR3 as a novel strategy to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-related Diseases. Based on readily available https://lauraj836mot3.mdkblog.com/profile